Corcept Therapeutics Incorporated (CORT) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. The company offers Korlym, an oral medication for the treatment of…
Source: Yahoo Finance
Sector & Industry
Corcept Therapeutics Incorporated operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Corcept Therapeutics Incorporated at a Glance
| Company | Corcept Therapeutics Incorporated |
| Ticker | CORT |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $111.62 |
| Market cap | $12.07B |
| P/E ratio (trailing) | 248.04 |
| EPS (trailing) | $0.45 |
| 52-week high | $126.38 |
| 52-week low | $28.66 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.45 |
| Return on equity (ROE) | 8.23% |
| Debt-to-equity | 1.33% |
| Average volume | 1.08M |
| Shares outstanding | 108.10M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 730 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is Corcept Therapeutics Incorporated's current P/E ratio?
- Corcept Therapeutics Incorporated (CORT) has a trailing P/E ratio of 248.04 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Corcept Therapeutics Incorporated's market capitalisation?
- Corcept Therapeutics Incorporated's market cap is $12.07B based on our latest snapshot. See how it ranks by market cap →
- What is CORT's 52-week range?
- Over the past 52 weeks, CORT has traded between $28.66 and $126.38. What does the 52-week range mean? →
- How volatile is Corcept Therapeutics Incorporated compared to the market?
- Corcept Therapeutics Incorporated has a beta of 0.45, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Corcept Therapeutics Incorporated pay a dividend?
- Corcept Therapeutics Incorporated does not currently pay a dividend according to our latest data.
- What exchange is CORT listed on?
- CORT is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Corcept Therapeutics Incorporated in?
- Corcept Therapeutics Incorporated is classified in the Healthcare sector. Compare with Healthcare peers →
Prefer raw numbers at a glance? Browse our size and reference charts for quick lookups.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →